SI3063273T1 - Vektor virusa gripe za viroterapijo - Google Patents
Vektor virusa gripe za viroterapijoInfo
- Publication number
- SI3063273T1 SI3063273T1 SI201431457T SI201431457T SI3063273T1 SI 3063273 T1 SI3063273 T1 SI 3063273T1 SI 201431457 T SI201431457 T SI 201431457T SI 201431457 T SI201431457 T SI 201431457T SI 3063273 T1 SI3063273 T1 SI 3063273T1
- Authority
- SI
- Slovenia
- Prior art keywords
- virotherapy
- influenza virus
- virus vector
- vector
- influenza
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
- C12N15/86—Viral vectors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/76—Viruses; Subviral particles; Bacteriophages
- A61K35/768—Oncolytic viruses not provided for in groups A61K35/761 - A61K35/766
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
- A61K38/193—Colony stimulating factors [CSF]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/52—Cytokines; Lymphokines; Interferons
- C07K14/53—Colony-stimulating factor [CSF]
- C07K14/535—Granulocyte CSF; Granulocyte-macrophage CSF
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/16011—Orthomyxoviridae
- C12N2760/16111—Influenzavirus A, i.e. influenza A virus
- C12N2760/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/16011—Orthomyxoviridae
- C12N2760/16111—Influenzavirus A, i.e. influenza A virus
- C12N2760/16132—Use of virus as therapeutic agent, other than vaccine, e.g. as cytolytic agent
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/16011—Orthomyxoviridae
- C12N2760/16111—Influenzavirus A, i.e. influenza A virus
- C12N2760/16141—Use of virus, viral particle or viral elements as a vector
- C12N2760/16143—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/16011—Orthomyxoviridae
- C12N2760/16111—Influenzavirus A, i.e. influenza A virus
- C12N2760/16141—Use of virus, viral particle or viral elements as a vector
- C12N2760/16145—Special targeting system for viral vectors
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/16011—Orthomyxoviridae
- C12N2760/16111—Influenzavirus A, i.e. influenza A virus
- C12N2760/16151—Methods of production or purification of viral material
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/16011—Orthomyxoviridae
- C12N2760/16111—Influenzavirus A, i.e. influenza A virus
- C12N2760/16161—Methods of inactivation or attenuation
- C12N2760/16162—Methods of inactivation or attenuation by genetic engineering
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Genetics & Genomics (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Zoology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Virology (AREA)
- Wood Science & Technology (AREA)
- Biochemistry (AREA)
- Microbiology (AREA)
- Immunology (AREA)
- General Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- Biotechnology (AREA)
- Public Health (AREA)
- Biomedical Technology (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Gastroenterology & Hepatology (AREA)
- Epidemiology (AREA)
- Mycology (AREA)
- Oncology (AREA)
- Plant Pathology (AREA)
- Physics & Mathematics (AREA)
- Toxicology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP13190511 | 2013-10-28 | ||
PCT/EP2014/073120 WO2015063085A1 (en) | 2013-10-28 | 2014-10-28 | Novel influenza virus vector for virotherapy |
EP14809770.2A EP3063273B8 (en) | 2013-10-28 | 2014-10-28 | Influenza virus vector for virotherapy |
Publications (1)
Publication Number | Publication Date |
---|---|
SI3063273T1 true SI3063273T1 (sl) | 2020-03-31 |
Family
ID=49515216
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SI201431457T SI3063273T1 (sl) | 2013-10-28 | 2014-10-28 | Vektor virusa gripe za viroterapijo |
Country Status (6)
Country | Link |
---|---|
US (2) | US10125374B2 (sl) |
EP (1) | EP3063273B8 (sl) |
CN (2) | CN111500631B (sl) |
ES (1) | ES2762174T3 (sl) |
SI (1) | SI3063273T1 (sl) |
WO (1) | WO2015063085A1 (sl) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104830811B (zh) * | 2015-06-05 | 2018-01-09 | 扬州大学 | H9n2亚型禽流感病毒ns1基因缺失减毒活疫苗候选株及其构建方法和应用 |
CN106562999B (zh) * | 2015-10-09 | 2019-11-01 | 中国人民解放军第三〇二医院 | ***的成套试剂与重组流感病毒 |
CN110167585B (zh) * | 2016-09-02 | 2024-03-08 | 美国卫生与公众服务部 | 稳定化的第2组流感血凝素茎区三聚体及其用途 |
WO2018152480A1 (en) * | 2017-02-20 | 2018-08-23 | Richard Postrel | Method for precise identification, targeting and delivery of directed therapies for destruction of cancerous cells |
CN112424367A (zh) * | 2018-04-26 | 2021-02-26 | 香港大学 | 具有抗病毒活性和递送活性的核酸分子和双功能肽,其组合物和方法 |
EP4251200A1 (en) * | 2020-11-30 | 2023-10-04 | BlueSky Immunotherapies GmbH | Novel replication deficient influenza a virus inducing high levels of type i interferon |
CN114908122B (zh) * | 2021-02-07 | 2024-05-07 | 广州恩宝生物医药科技有限公司 | 一种用于表达外源蛋白的新型流感病毒载体及其构建方法 |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6800288B2 (en) | 2000-03-02 | 2004-10-05 | Polymun Scientific Immunbiologische Forschung Gmbh | Recombinant influenza A viruses |
ES2327103T3 (es) | 2000-09-25 | 2009-10-26 | Polymun Scientific Immunbiologische Forschung Gmbh | Vacuna viva de influenzavirus y procedimiento de fabricacion. |
WO2004111249A2 (en) | 2003-06-13 | 2004-12-23 | Polymun Scientific Immunbiologische Forschung Gmbh | Protein constructs containing caspase recognition sites |
CA2610632C (en) * | 2004-06-01 | 2022-10-04 | Mount Sinai School Of Medicine Of New York University | Genetically engineered swine influenza virus and uses thereof |
CN102586199A (zh) * | 2004-11-11 | 2012-07-18 | 索尔瓦生物学有限公司 | 有缺陷的流感病毒颗粒 |
EP2048237A1 (en) | 2007-10-05 | 2009-04-15 | Avir Green Hills Biotechnology Research Development Trade Ag | Replication deficient Influenza virus for the expression of heterologous sequences |
CN101532030A (zh) * | 2009-04-21 | 2009-09-16 | 中国科学院广州生物医药与健康研究院 | 一种na片段携带外源基因的重组流感病毒载体及其制备方法和应用 |
WO2011014504A1 (en) * | 2009-07-27 | 2011-02-03 | Mount Sinai School Of Medicine Of New York University | Recombinant influenza virus vectors and uses thereof |
EP2708552A1 (en) | 2012-09-12 | 2014-03-19 | Medizinische Universität Wien | Influenza virus |
-
2014
- 2014-10-28 US US15/031,715 patent/US10125374B2/en active Active
- 2014-10-28 CN CN202010084787.XA patent/CN111500631B/zh active Active
- 2014-10-28 CN CN201480071322.3A patent/CN105849270B/zh active Active
- 2014-10-28 SI SI201431457T patent/SI3063273T1/sl unknown
- 2014-10-28 ES ES14809770T patent/ES2762174T3/es active Active
- 2014-10-28 WO PCT/EP2014/073120 patent/WO2015063085A1/en active Application Filing
- 2014-10-28 EP EP14809770.2A patent/EP3063273B8/en active Active
-
2018
- 2018-10-16 US US16/162,170 patent/US10480013B2/en active Active
Also Published As
Publication number | Publication date |
---|---|
WO2015063085A1 (en) | 2015-05-07 |
EP3063273A1 (en) | 2016-09-07 |
US10480013B2 (en) | 2019-11-19 |
EP3063273B1 (en) | 2019-10-16 |
US20190032084A1 (en) | 2019-01-31 |
CN111500631B (zh) | 2024-03-29 |
CN111500631A (zh) | 2020-08-07 |
CN105849270B (zh) | 2020-02-28 |
EP3063273B8 (en) | 2020-12-30 |
CN105849270A (zh) | 2016-08-10 |
US20160264996A1 (en) | 2016-09-15 |
US10125374B2 (en) | 2018-11-13 |
ES2762174T3 (es) | 2020-05-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL276210A (en) | MERS-COV vaccine | |
HK1222882A1 (zh) | 流感病毒重配 | |
PL3083969T3 (pl) | Układ do wytwarzania wektorów wirusowych | |
GB201405834D0 (en) | Oncolytic virus | |
HK1218511A1 (zh) | 乙型流感病毒重配 | |
HK1218872A1 (zh) | 乙型肝炎疫苗 | |
SI3063273T1 (sl) | Vektor virusa gripe za viroterapijo | |
GB201310432D0 (en) | Virus Production | |
GB201313201D0 (en) | Virus Detection | |
HK1223644A1 (zh) | 呼吸道合胞病毒半活疫苗 | |
HK1217638A1 (zh) | 流感病毒重配 | |
HK1217206A1 (zh) | 疫苗 | |
HK1223395A1 (zh) | 病毒載體製備 | |
HK1223643A1 (zh) | 呼吸道合胞病毒半活疫苗 | |
GB201301119D0 (en) | Viral vaccines | |
GB2526222B (en) | Viral peptides | |
SG11201507455WA (en) | Hepatitis b virus vaccines | |
GB201314063D0 (en) | Virus | |
GB201306812D0 (en) | Virus | |
GB201304827D0 (en) | Infulenza virus reassortment | |
GB201308173D0 (en) | Viral Preparations | |
GB201320646D0 (en) | Vaccine | |
GB201315556D0 (en) | Vaccine | |
AU2013905065A0 (en) | Viral vaccine | |
AU2013905043A0 (en) | Viral vaccine |